RhumbLine Advisers’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-30,467
| Closed | -$68K | – | 3143 |
|
|
2021
Q1 | $68K | Buy |
30,467
+100
| +0.3% | +$223 | ﹤0.01% | 2965 |
|
|
2020
Q4 | $75K | Buy |
30,367
+3,833
| +14% | +$9.47K | ﹤0.01% | 2996 |
|
|
2020
Q3 | $65K | Sell |
26,534
-8,305
| -24% | -$20.3K | ﹤0.01% | 2936 |
|
|
2020
Q2 | $124K | Buy |
+34,839
| New | +$124K | ﹤0.01% | 2919 |
|
|
2019
Q2 | – | Sell |
-42,145
| Closed | -$83K | – | 3023 |
|
|
2019
Q1 | $83K | Sell |
42,145
-415
| -1% | -$817 | ﹤0.01% | 2884 |
|
|
2018
Q4 | $56K | Buy |
42,560
+13,180
| +45% | +$17.3K | ﹤0.01% | 2936 |
|
|
2018
Q3 | $72K | Sell |
29,380
-800
| -3% | -$1.96K | ﹤0.01% | 2892 |
|
|
2018
Q2 | $101K | Buy |
30,180
+3,580
| +13% | +$12K | ﹤0.01% | 2871 |
|
|
2018
Q1 | $113K | Buy |
26,600
+1,820
| +7% | +$7.73K | ﹤0.01% | 2727 |
|
|
2017
Q4 | $82K | Sell |
24,780
-6,172
| -20% | -$20.4K | ﹤0.01% | 2794 |
|
|
2017
Q3 | $118K | Buy |
30,952
+520
| +2% | +$1.98K | ﹤0.01% | 2851 |
|
|
2017
Q2 | $134K | Buy |
+30,432
| New | +$134K | ﹤0.01% | 2859 |
|